Orforglipron
RESTRAIN-SUI
Eli Lilly · Phase 3 · Recruiting · Enrollment 1000
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.
Disease Pipeline Tools Obesity
Obesity
Programs, trials, and reported weight change for obesity and overweight.
Orforglipron
Eli Lilly · Phase 3 · Recruiting · Enrollment 1000
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.